| Literature DB >> 35751028 |
Fang-We Chiu1, Chung-Wang Ko2,3, Ying-Cheng Lin4, Szu-Chia Liao4,5, Chung-Hsin Chang4, Chia-Chang Chen4, Wan-Tzu Lin4.
Abstract
BACKGROUND: Cecal ulcers are sometimes encountered in asymptomatic individuals. Their clinical outcomes and management recommendations remain uncertain.Entities:
Keywords: Asymptomatic; Cecal ulcer; Crohn’s disease; Endoscopy; Inflammatory bowel disease; Intestinal tuberculosis; Ulcerative colitis
Mesh:
Year: 2022 PMID: 35751028 PMCID: PMC9229120 DOI: 10.1186/s12876-022-02383-x
Source DB: PubMed Journal: BMC Gastroenterol ISSN: 1471-230X Impact factor: 2.847
Fig. 1Flowchart of participant recruitments and outcomes. NSAID non-steroidal anti-inflammatory drug
Demographic characteristics of patients with asymptomatic cecal ulcers
| Resolved (n = 20) | Progression to disease (n = 4) | ||
|---|---|---|---|
| Age | 50.40 (25.8–69.7) | 53.35 (52.7–59) | 0.304 |
| Gender | 0.272 | ||
| Female | 7 (35.00%) | 3 (75.00%) | |
| Male | 13 (65.00%) | 1 (25.00%) | |
| Lab data | |||
| WBC (/µL) | 6020.00 (3000–12,400) | 7685.00 (3960–12,500) | 0.785 |
| Hemoglobin (g/dL) | 14.9 (12.8–16.5) | 14.9 (13.6–15.8) | 0.631 |
| CRP (mg/dL) | 0.14 (0.01–0.79) | 1.22 (0.01–4.79) | 0.237 |
| Creatinine (mg/dL) | 0.91 (0.46–1.29) | 0.78 (0.64–1.09) | 0.491 |
| HbA1c (%) | 5.80 (5.4–6.2) | 5.55 (5.4–8.8) | 0.608 |
| Guaiac-based FOBT | Negative (19), Trace (1) | Negative (4) | NA |
| Tobacco smoking | 5 (25.00%) | 0 (0.00%) | 0.544 |
Continuous data are expressed as median (Range). Categorical data are expressed as number and percentage
WBC white blood cell, CRP C-reactive protein, FOBT fecal occult blood test, NA not available
Fig. 2Cecal ulcers with irregular fold. a The patient was later diagnosed as Crohn’s disease. b The patient was later diagnosed as intestinal tuberculosis
Endoscopic characteristics of patients with asymptomatic cecal ulcers
| Resolved (n = 20) | Progression to disease (n = 4) | ||
|---|---|---|---|
| Endoscopic finding | |||
| Ulcer number > 1 | 6 (30%) | 2 (50%) | 0.578 |
| Ulcer size (cm) | 0.40 (0.2–1.2) | 1.75 (0.2–2) | 0.088 |
| Ulcer size ≥ 1 cm | 3 (15%) | 3 (75%) | 0.035** |
| Ulcer with irregular fold | 1 (5.00%) | 3 (75.00%) | 0.008** |
| Terminal ileum involvement | 2 (15.38%) | 4 (100.00%) | 0.006** |
| Time to spontaneous endoscopic remission (months) | 24.00 (12–84) | NA | |
| Longest endoscopic follow up period (months) | 36.00 (14–119) | 47.50 (12–65) | 0.961 |
Continuous data are expressed as median (Range). Categorical data are expressed as number and percentage
NA not available
**p < 0.05